This Education Stock Posted 34% EPS Growth, So Why Did One Fund Exit a $10.7 Million Stake?

Peregrine Asset Advisers fully exited its 69,012-share position in Adtalem Global Education (ATGE) in Q4, a stake worth roughly $10.66 million that previously represented about 3.2% of the fund’s AUM, as shown in a Feb. 2 SEC filing; the fund’s top holdings now tilt toward large-cap tech names (e.g., LGDX, GOOGL, AAPL, NVDA, MSFT). Adtalem reported strong operating results — fiscal Q2 revenue $503m (+12.4% YoY), adjusted EPS $2.43 (+34%), enrollment +6.3% to 97,010, TTM revenue $1.89bn and net income $253.25m — and raised full-year adjusted EPS guidance to $7.80–$8.00 while authorizing a $750m share repurchase program, indicating the sale likely reflects portfolio repositioning rather than company weakness.

Analysis

Market structure: Peregrine’s $10.66M exit of ATGE (3.2% of its AUM previously) is a classic reallocative flow from mid-cap education into mega-cap tech (GOOGL, AAPL, NVDA, MSFT). Direct beneficiaries are large-cap, low‑beta and index‑linked names that absorb rebalanced inflows and can see multiple expansion; direct losers are mid‑cap education/skills names that suffer transient selling and risk multiple compression if outflows persist.

Risk assessment: Tail risks for ATGE include regulatory shifts to Title IV/student‑aid or accreditation setbacks that could trigger 20–40% downside in a stress scenario; for tech, a macro growth shock or semiconductor downturn could erase 20–30% of gains. In the next 1–4 trading days impact is likely muted, over weeks momentum and rebalances matter, and over 2–8 quarters fundamentals (enrollment, buyback execution, guidance) will determine direction. Hidden dependencies: ATGE valuation is levered to government funding and online enrollment trends; buyback authorization ($750M through 2028) is a timing/capacity risk, not immediate liquidity support.

Trade implications: Tactical: establish a 1–2% notional long in NVDA (or NVDA 3‑month call spread: buy Jun 2026 700C / sell 800C) targeting +20–30% in 3–6 months with a 12% stop. Relative/value: pair trade long MSFT (1–2% position) vs short ATGE (0.5–1% or buy 3‑month ATGE puts with strike ~95) to capture rotation premium; set stop-losses at 10% and targets at 20–30%. Sector rotation: trim mid‑cap education exposure by 50–100 bps and redeploy to tech/healthcare staffing over next 4–8 weeks.

Contrarian angles: The market may be overstating the signal from a single manager exit—ATGE reported +12% revenue growth and a $750M repurchase authorization, which can materially offset supply if executed (monitor quarterly buyback cadence). If ATGE dips below $95 on flow‑driven selling, consider opportunistic accumulation size 0.5–1% with a 12–18 month horizon; beware crowding into mega‑caps which magnifies systemic tail risk if macro inflects.

Key Decisions for Investors

• Establish a 1–2% notional long position in NVDA (or execute a 3‑month call spread: buy Jun 2026 700C / sell 800C) targeting +20–30% in 3–6 months; set an initial stop-loss at 12% adverse move.
• Open a relative-value pair: long MSFT (1–2% position) and short ATGE (0.5–1% position) to capture rotation; exit if MSFT falls >12% or if ATGE rallies >25% from entry within 3 months.
• Buy 3‑month ATGE protective puts (strike ~95) size 0.5–1% as insurance against regulatory or enrollment shocks, or alternatively initiate a small contrarian long (0.5–1%) if ATGE trades below $95 with target $125 by Q4 2026 and stop at -15%.
• Reduce aggregate mid‑cap education exposure by 50–100 bps within 2–4 weeks and redeploy to defensive healthcare staffing or mega‑cap tech over next 4–8 weeks; prioritize liquidity and set portfolio-level stop losses of 8–12% per position.
• Monitor three specific catalysts over next 30–90 days before scaling: ATGE quarterly enrollment/guidance cadence, actual buyback execution (quarterly spent >$50M signals follow-through), and Fed policy guidance—if two of three are negative, close or hedge positions within 10 trading days.